According to the latest research report by IMARC Group, The global xerostomia (dry mouth disease) therapeutics market size reached US$ 739.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 985.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.13% during 2024-2032. More Info:- https://www.imarcgroup.com/xerostomia-therapeutics-market